141 related articles for article (PubMed ID: 16288930)
1. The neurotoxin 2'-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF.
Luellen BA; Szapacs ME; Materese CK; Andrews AM
Neuropharmacology; 2006 Mar; 50(3):297-308. PubMed ID: 16288930
[TBL] [Abstract][Full Text] [Related]
2. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM
J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848
[TBL] [Abstract][Full Text] [Related]
3. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.
Szapacs ME; Numis AL; Andrews AM
Neurobiol Dis; 2004 Aug; 16(3):572-80. PubMed ID: 15262269
[TBL] [Abstract][Full Text] [Related]
4. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
Andrews AM; Murphy DL
J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.
Andrews AM; Ladenheim B; Epstein CJ; Cadet JL; Murphy DL
Mol Pharmacol; 1996 Dec; 50(6):1511-9. PubMed ID: 8967972
[TBL] [Abstract][Full Text] [Related]
7. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior.
Chourbaji S; Hellweg R; Brandis D; Zörner B; Zacher C; Lang UE; Henn FA; Hörtnagl H; Gass P
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):28-36. PubMed ID: 14969734
[TBL] [Abstract][Full Text] [Related]
8. 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
Unger EL; Mazzola-Pomietto P; Murphy DL; Andrews AM
J Pharmacol Exp Ther; 2002 Nov; 303(2):527-33. PubMed ID: 12388632
[TBL] [Abstract][Full Text] [Related]
9. Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.
Szapacs ME; Mathews TA; Tessarollo L; Ernest Lyons W; Mamounas LA; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):81-92. PubMed ID: 15589338
[TBL] [Abstract][Full Text] [Related]
10. Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice.
Luellen BA; Bianco LE; Schneider LM; Andrews AM
Genes Brain Behav; 2007 Jul; 6(5):482-90. PubMed ID: 17156118
[TBL] [Abstract][Full Text] [Related]
11. Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice.
Ren-Patterson RF; Cochran LW; Holmes A; Sherrill S; Huang SJ; Tolliver T; Lesch KP; Lu B; Murphy DL
J Neurosci Res; 2005 Mar; 79(6):756-71. PubMed ID: 15672416
[TBL] [Abstract][Full Text] [Related]
12. Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat.
Jacobsen JP; Mørk A
Brain Res; 2006 Sep; 1110(1):221-5. PubMed ID: 16876769
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
Martínez-Turrillas R; Moyano S; Del Río J; Frechilla D
Neurosci Lett; 2006 Jul; 402(1-2):126-30. PubMed ID: 16644117
[TBL] [Abstract][Full Text] [Related]
14. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
[TBL] [Abstract][Full Text] [Related]
15. Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Chen LW; Hu HJ; Liu HL; Yung KK; Chan YS
Neuroscience; 2004; 126(4):941-53. PubMed ID: 15207328
[TBL] [Abstract][Full Text] [Related]
16. Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels.
Christensen R; Marcussen AB; Wörtwein G; Knudsen GM; Aznar S
Exp Neurol; 2008 Mar; 210(1):164-71. PubMed ID: 18053988
[TBL] [Abstract][Full Text] [Related]
17. Opposite morphological responses of partially denervated cortical serotonergic and noradrenergic axons to repeated stress in adult rats.
Liu Y; Ishida Y; Shinoda K; Furukawa S; Nakamura S
Brain Res Bull; 2004 Jul; 64(1):67-74. PubMed ID: 15275959
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine.
Andrews AM; Murphy DL
Eur J Pharmacol; 1993 Dec; 250(2):215-21. PubMed ID: 8112382
[TBL] [Abstract][Full Text] [Related]
19. Dietary restriction changes behaviours in brain-derived neurotrophic factor heterozygous mice: role of serotonergic system.
Koizumi H; Hashimoto K; Iyo M
Eur J Neurosci; 2006 Oct; 24(8):2335-44. PubMed ID: 17074054
[TBL] [Abstract][Full Text] [Related]
20. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
Andrews AM; Murphy DL
J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]